A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD (Q21093202)

15 August 2022

Timothy E Wilens

1

Timothy E

Wilens

1 reference

15 August 2022

Thorsten Klint

2

Thorsten

Klint

1 reference

15 August 2022

Lenard Adler

3

Lenard

Adler

1 reference

15 August 2022

Scott West

4

Scott

West

1 reference

15 August 2022

Ole Graff

6

Ole

Graff

1 reference

15 August 2022

Birgit Mikkelsen

7

Birgit

Mikkelsen

1 reference

Behavioral and Brain Functions

15 August 2022

language of work or name

English

0 references

publication date

2008

0 references

published in

0 references

volume

4

0 references

issue

1

0 references

page(s)

24

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1744-9081-4-24

0 references

cites work

A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

The worldwide prevalence of ADHD: is it an American condition?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

Neuropsychological functioning in people with ADHD across the lifespan

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

Nonstimulant treatment of adult attention-deficit/hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

ADHD treatment across the life cycle.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

Impact of comorbidity in adults with attention-deficit/hyperactivity disorder.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

Non-stimulant treatment for Attention-Deficit/Hyperactivity Disorder.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

Non-stimulant treatment of attention-deficit/hyperactivity disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

Nicotinic receptor subtypes and cognitive function

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

Cognitive effects of nicotine

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

Non-stimulant treatments for ADHD.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

Methylphenidate in Hyperkinetic Children: Differences in Dose Effects on Learning and Social Behavior

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

Benefits of rivastigmine on attention in dementia associated with Parkinson disease

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

Attention-Deficit/Hyperactivity Disorder in Adults

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

Dopamine transporter density in patients with attention deficit hyperactivity disorder.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442604

Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography

29 November 2018

1 reference

12 December 2020

Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. American Psychiatric Association

1 reference

12 December 2020

Attention-deficit hyperactivity disorder and comorbid substance use disorders in adults

1 reference

12 December 2020

ADHD is associated with early initiation of cigarette smoking in children and adolescents

1 reference

12 December 2020

Identifiers

DOI

10.1186/1744-9081-4-24

0 references